Allianz Asset Management
CLCD

Allianz Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Allianz Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-29,989
Closed -$1.09M – 2726
2016
Q4 		$1.09M Buy
+29,989
New +$1.06M ﹤0.01% 2186

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Allianz Asset Management's CLCD Position: Q1 2017 in Review

Allianz Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 29,989 shares — an estimated $1.09M sold.

Allianz Asset Management first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $1.09M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Allianz Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Allianz Asset Management sold 29,989 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.09M.
  • Allianz Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Allianz Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $1.09M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Allianz Asset Management's 13F filing for Q1 2017, filed 15 May 2017.